B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...
Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...
In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...
John T. Wilson is in the Department of Chemical and Biomolecular Engineering and the Department of Biomedical Engineering at Vanderbilt University, Nashville, Tennessee 37235, USA, and in the ...
Adaptimmune is rolling out its T cell therapy Tecelra for synovial sarcoma, recording $1.2 million in sales since its ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
Clinical Trials Arena on MSN12d
Orca Bio makes a splash as T-cell therapy cuts GvHD in blood cancer patientsGraft versus host disease (GvHD) is a complication from stem cell transplants where the patient recognises the cells as ...
A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets ...
What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.
Mar. 11, 2025 — Researchers have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback